loadpatents
Patent applications and USPTO patent grants for Transcend Cytotherapy Co.,Ltd.The latest application filed is for "small molecule-induced method for directly reprogramming human fibroblasts into liver cells".
Patent | Date |
---|---|
Small Molecule-Induced Method for Directly Reprogramming Human Fibroblasts into Liver Cells App 20200277568 - Zhang; Peilin | 2020-09-03 |
Method for using small molecule compounds to induce human tumor cells to be directly reprogrammed into non-oncogenic cells Grant 10,463,641 - Zhang , et al. No | 2019-11-05 |
Method for Inducing Targeted Differentiation of Human Stem Cells Toward Hepatic Cells App 20190002825 - ZHANG; Pei-Lin ;   et al. | 2019-01-03 |
Method for Using Small Molecule Compounds to Induce Human Tumor Cells to Be Directly Reprogrammed Into Non-Oncogenic Cells App 20180353454 - ZHANG; Pei-Lin ;   et al. | 2018-12-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.